Human Growth Hormone Market

Growth hormone (GH), also known as somatotropin (or as human growth hormone in its human form), is a peptide hormone that stimulates growth, cell reproduction, and cell regeneration in humans and other animals. It is thus important in human development. It is a type of mitogen which is specific only to certain kinds of cells. Growth hormone is a 191-amino acid, single-chain polypeptide that is synthesized, stored, and secreted by somatotropic cells within the lateral wings of the anterior pituitary gland.

Human Growth Hormone Market contains market size and forecasts of Human Growth Hormone in global, including the following market information:

Global Human Growth Hormone Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Human Growth Hormone Market Sales, 2017-2022, 2023-2028, (Million IU)

Global top five Human Growth Hormone companies in 2021 (%)

The global Human Growth Hormone market was valued at 4584.2 million in 2021 and is projected to reach US$ 5735.9 million by 2028, at a CAGR of 3.3% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Powder Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Human Growth Hormone include Novo Nordisk, Pfizer, Eli Lilly, Merck Serono, F. Hoffmann-La Roche, Ferring Pharmaceuticals, GeneScience Pharmaceuticals, Ipsen and LG Life Sciences, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Human Growth Hormone manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Human Growth Hormone Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Million IU)

Global Human Growth Hormone Market Segment Percentages, by Type, 2021 (%)

Powder

Solvent

Global Human Growth Hormone Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Million IU)

Global Human Growth Hormone Market Segment Percentages, by Application, 2021 (%)

Growth Hormone Deficiency (GHD)

Turner Syndrome

Chronic Renal Insufficiency

Prader Willi Syndrome

Small for Gestational Age

SHOX Deficiency

Others

Global Human Growth Hormone Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Million IU)

Global Human Growth Hormone Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Human Growth Hormone revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Human Growth Hormone revenues share in global market, 2021 (%)

Key companies Human Growth Hormone sales in global market, 2017-2022 (Estimated), (Million IU)

Key companies Human Growth Hormone sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Novo Nordisk

Pfizer

Eli Lilly

Merck Serono

F. Hoffmann-La Roche

Ferring Pharmaceuticals

GeneScience Pharmaceuticals

Ipsen

LG Life Sciences

Sandoz International

Anhui Anke Biotechnology